Search results
Results from the WOW.Com Content Network
A lack of international leadership, President-elect Donald Trump's second term and AI all made the list of the biggest risks the world faces in 2025, according to the Eurasia Group, which is a ...
Ian Arthur Bremmer (born November 12, 1969) is an American political scientist, author, and entrepreneur focused on global political risk. He is the founder and president of Eurasia Group , a political risk research and consulting firm.
The global uncertainty created by an oscillation of power between left and right—from Barack Obama to Donald Trump to Joe Biden and back to Trump—in the world’s only military superpower has ...
Atorvastatin, sold under the brand name Lipitor among others, is a statin medication used to prevent cardiovascular disease in those at high risk and to treat abnormal lipid levels. [6] For the prevention of cardiovascular disease, statins are a first-line treatment. [6] It is taken by mouth. [6]
In 2017, Eurasia Group launched a media company called GZERO Media, [10] featuring digital programming as well as a US national public television show called GZERO World with Ian Bremmer. [11] On January 3, 2023, at Bloomberg, Ian Bremmer discussed the TOP-10 risks for the world to face in 2023 according to Eurasia Group. [12]
Soon after the meeting to deal with, and put aside, the concerns about the drug’s safety when taken by seniors, it became clearer that serious side effects in children might be an equally significant problem. The Janssen doctors and statisticians now had more complete results from the long-term study of children and adolescents using Risperdal.
The risks are “unusually large but two-sided” the duo adds in a note seen by Fortune, explaining: “Growth could be stronger than we are forecasting (perhaps even exceeding 3%) if the ...
But the largest study done yet by J&J of the effects of long-term Risperdal use among children and adolescents—in which, according to the study’s protocol, “special attention” was paid to prolactin—had now found that of 319 children, including 266 males, 8.6 percent of the males had developed gynecomastia, or breasts.